A series of novel 1,2,3-triazole derivatives incorporating 3′-deoxythymidine were designed, synthesised and characterised. Antibacterial activity against Escherichia coli and Staphylococcus aureus was evaluated for all of the synthesised compounds and compared against standard antibiotic drugs, streptomycin sulfate and doxycycline, as controls. Some compounds showed potential antibacterial activity towards E. coli, and the best minimum inhibitory concentration was 0.14 mM. Preliminary structure-activity relationships and computational simulations were also studied.
JiangY.Q., RenB.Q., LvX.M., ZhangW.W., LiW., and XuG.Q., J. Chem. Res., 2015, 39, 243.
14.
MajumdarK.C., and GanaiS., Tetrahedron Lett., 2013, 54, 6192.
15.
Clinical and Laboratory Standards Institute (CLSI), Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 7th edn. CSLI document M7-A7. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA, 2012.
